Valtoco (NRL-1)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 01/13/2020
Pipeline Type
Newly Marketed
Phase Of Development
Phase 3
Sponsors and Collaborators
Neurelis
Mechanism of Action
Mechanism Description
Diazepam as an intranasal spray
Populations Tested In
Acute Repetitive Seizures
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link